Back to news

Comar Announces Brian Larkin as President and Chief Executive Officer

September 28, 2022

Comar has named Brian Larkin as its new President and Chief Executive Officer, succeeding Mike Ruggieri, who will transition to the Chairman role and remain on the Board of Directors. Under Mr. Ruggieri’s 15 years of leadership, Comar evolved from a single site family-owned business to a professionally backed, multi-national company with expanded customer relationships, broad innovation and design resources, and state-of-the-art manufacturing capabilities.

“Brian is the right leader for Comar,” said Mr. Ruggieri, Chairman of the Board. “Brian’s extensive background in the healthcare industry combined with his innate business development skills should help Comar strengthen partnerships, develop strategic alliances, and expand our international sales presence. In addition, we believe his customer-centric leadership style will help focus Comar as we pursue our strategic ambitions.”

Mr. Larkin’s career spans more than three decades of commercial and executive leadership roles in public and private equity-backed companies focused on medical device and pharmaceutical companies. Prior to joining Comar, Mr. Larkin held several key executive positions, including President and Chief Executive Officer of SP Industries, Vice President and General Manager of Becton Dickinson’s U.S. Diabetes Care business, Senior Vice President and General Manager for LifeCell Corporation, and Corporate Vice President of Integra Lifesciences. He also currently serves on the Board of Directors for Dynatronics Corporation.

“I am excited to build upon the strong foundation that Mike and his team have established at Comar and eager to contribute to its next phase of growth,” said Mr. Larkin. “I look forward to partnering with Comar’s employees and valued customers to capitalize on emerging growth trends in the medical and packaging industries while continuing to provide the highest quality products and services.”

Eric Kanter, Managing Director at Morgan Stanley Capital Partners (MSCP), which manages the investment funds backing Comar said, “This is a unique opportunity to bring a fresh perspective to Comar while maintaining seamless continuity. Mike will remain an integral part of the company, while Brian will bring a new vision and a strong customer lens to all aspects of the business. On behalf of MSCP, we would like to thank Mike Ruggieri for his many years of leadership and service to the company, and we look forward to continuing to benefit from his experience and expertise on the Board.”

RECENT NEWS

June 5, 2024

Comar Celebrates 75 Years of Innovation

Comar proudly announces its 75th anniversary as a leading contract manufacturer for healthcare companies worldwide and as a leading provider of primary packaging and dispensing products. Founded on the guiding principles of excellence, dedication, and customer-centricity, Comar has established itself as a trusted partner for clients in the Medical, Pharmaceutical, Consumer Healthcare, Personal & Home

Read more

May 28, 2024

Comar Achieves CE Certification for Medical Devices Under New EU MDR Regulations

Comar, a leading provider of innovative medical devices and packaging solutions, is thrilled to announce a significant achievement. After rigorous preparation, they successfully obtained their CE certificate under the latest EU Medical Device Regulations (EU MDR 2017/745). This certification is a significant milestone, marking Comar’s compliance with the latest European Union medical device standards. The

Read more

February 8, 2022

Comar Expands Internationally & Acquires Automatic Plastics Ltd.

Voorhees, New Jersey, USA, February 8, 2022 – Comar, a premier supplier of custom medical devices & assemblies and specialty packaging solutions, announced today it has acquired Automatic Plastics Ltd., a contract manufacturer of injection molded products primarily for the medical device and pharmaceutical sectors. The company is headquartered in Wicklow, Ireland just south of

Read more